157 related articles for article (PubMed ID: 23445116)
1. Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and antiphospholipid antibodies in Czech women.
Subrt I; Ulcova-Gallova Z; Cerna M; Hejnalova M; Slovanova J; Bibkova K; Micanova Z
Am J Reprod Immunol; 2013 Jul; 70(1):54-8. PubMed ID: 23445116
[TBL] [Abstract][Full Text] [Related]
2. Recurrent pregnancy loss and frequency of eight antiphospholipid antibodies and genetic thrombophilic factors in Czech women.
Subrt I; Ulcova-Gallova Z; Bibkova K; Micanova Z; Hejnalova M; Cerna M; Hradecky L; Novotny Z
Am J Reprod Immunol; 2008 Mar; 59(3):193-200. PubMed ID: 18275512
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
[TBL] [Abstract][Full Text] [Related]
4. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study.
Kim JJ; Choi YM; Lee SK; Yang KM; Paik EC; Jeong HJ; Jun JK; Han AR; Hong MA
Am J Reprod Immunol; 2014 Dec; 72(6):571-6. PubMed ID: 25078885
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
[TBL] [Abstract][Full Text] [Related]
6. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
[TBL] [Abstract][Full Text] [Related]
7. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
[TBL] [Abstract][Full Text] [Related]
8. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.
Haralambous E; Hibberd ML; Hermans PW; Ninis N; Nadel S; Levin M
Crit Care Med; 2003 Dec; 31(12):2788-93. PubMed ID: 14668616
[TBL] [Abstract][Full Text] [Related]
9. Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women.
Jeon YJ; Kim YR; Lee BE; Choi YS; Kim JH; Shin JE; Rah H; Cha SH; Lee WS; Kim NK
Thromb Haemost; 2013 Oct; 110(4):742-50. PubMed ID: 23903286
[TBL] [Abstract][Full Text] [Related]
10. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM
Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M
Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325
[TBL] [Abstract][Full Text] [Related]
12. [Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients].
Guan L; Ji X; Wang J; Zhang A; Zhang Y; Zhao L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):393-6. PubMed ID: 12362314
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis.
Huang Z; Tang W; Liang Z; Chen Q; Li M; Li Y; Lao S; Pan H; Huang L; Huang M; Hu X; Zhao J
Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].
Aĭsina RB; Mukhametova LI; Ostriakova EV; Seredavkina NV; Patrushev LI; Patrusheva NL; Reshetniak TM; Gulin DA; Gershkovich KB; Nasonov EL; Varfolomeev SD
Biomed Khim; 2014; 60(1):72-93. PubMed ID: 24749249
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism is Associated with Reproductive Failure: Metabolic, Hormonal, and Immune Profiles.
Salazar Garcia MD; Sung N; Mullenix TM; Dambaeva S; Beaman K; Gilman-Sachs A; Kwak-Kim J
Am J Reprod Immunol; 2016 Jul; 76(1):70-81. PubMed ID: 27145077
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.
Kurzawińska G; Barlik M; Drews K; Różycka A; Seremak-Mrozikiewicz A; Ożarowski M; Klejewski A; Czerny B; Wolski H
Ginekol Pol; 2016; 87(4):271-6. PubMed ID: 27321098
[TBL] [Abstract][Full Text] [Related]
18. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
Jusić A; Balić D; Avdić A; Pođanin M; Balić A
Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
[TBL] [Abstract][Full Text] [Related]
19. Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis.
Su MT; Lin SH; Chen YC; Kuo PL
Thromb Haemost; 2013 Jan; 109(1):8-15. PubMed ID: 23179239
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
